BSE’s Surveillance Department (DOSS) sought clarifications from two listed companies regarding news articles appearing in newspapers, websites, and television channels. The exchange issued this notice (20260423-24) to inform members and investors about the accuracy of such reports. Amara Raja Energy & Mobility Ltd has submitted its reply, while Dr Reddys Laboratories Ltd’s response is still awaited.

Key Points

• BSE Surveillance proactively sought clarifications from companies to verify news articles circulating in media.
• Amara Raja Energy & Mobility Ltd (Scrip Code: 500008) has submitted its clarification reply (referenced from moneycontrol.com article).
• Dr Reddys Laboratories Ltd (Scrip Code: 500124) has not yet submitted its reply (referenced from cnbctv18.com article).
• The notice was issued by Deputy Vice President Sanjay Jain and Manager Shreya Ghose from the Surveillance department.

Regulatory Changes

No regulatory changes are introduced by this circular. It is a standard surveillance notice informing the market of clarification requests sent to listed companies.

Compliance Requirements

• Dr Reddys Laboratories Ltd (Scrip Code: 500124) is expected to submit its clarification to BSE regarding the news article published on cnbctv18.com.
• No action is required from members or investors at this stage.

Important Dates

• Notice Date: 23 April 2026
• No explicit deadline stated for Dr Reddys’ pending reply.

Impact Assessment

This is a low-impact informational notice. Investors holding or tracking Amara Raja Energy & Mobility Ltd (500008) may refer to the attached reply for clarification on the related news article. Those tracking Dr Reddys Laboratories Ltd (500124) should note that a clarification is pending and watch for a subsequent BSE notice once the reply is received. No trading restrictions or regulatory actions are indicated.